Novo Nordisk recently released their oral version of their GLP-1 agonist Ozempic/Semaglutide. It is a daily oral pill designed to treat type 2 diabetes but the hormone the medication mimics also has a god weight loss effect. The injectable versions of GLP-1 agonists are demonstrating terrific weight loss effects. How does Rybelsus stack up. Watch and find out.

The weight loss pill has finally landed. Rybelsus [wfI10MnZi]

Novo Nordisk recently released their oral version of their GLP-1 agonist Ozempic/Semaglutide. It is a daily oral pill designed to treat type 2 diabetes but the hormone the medication mimics also has a god weight loss effect. The injectable versions of GLP-1 agonists are demonstrating terrific weight loss effects. How does Rybelsus stack up. Watch and find out.